Clinical Trial Update: A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating pembrolizumab with lenvatinib for women with advanced uterine carcinosarcoma. The study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Carcinosarcoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING